After 8 months of consolidation, ENPH formed a nice cup and handle pattern with volume shrinking. Q3 earning surprise will make stock price gap up above pivot at $185 and create a nice chance to reach prior high at $230.
ZI has great fundamentals, but price was some how suppressed. Using 6 months of time, it completed a great head and shoulder pattern. After its 2021 Q2 report, the price finally broke out its pivot at $54 with huge volume (10 times average). Finally, ZI got some institute's attention!
ENPH next quarter's revenue (2021 Q2) is expected to grow 156%. The stock has done a 3 month correction over 50%. 6/10/2021 MACD crossed up 0. 6/17/2021 price broke up 3C $153 with volume increase. But, volume is not enough to break up pivot $173. If the stock pull back near 20 wma will be a good change to buy. I expect the stock will challenge previous high...
ROKU's 2021 Q1 sales growth was 79%, where platform sales grew 100%. 2021/6/17 MACD crossed up 0 and finished a near 4 month VCP. Then the stock broke up 3C $355 with increased volume reaching pivot price $426. The stock is a buy under both fundamental and technical analysis. If it pull back to 20 wma will be last chance to enter.
APPS 2021 sales growth is expected to be 255%. After a 48% correction, its MACD just crossed 0 2days ago. And finished a Cup & Handle patter. Next Price Target is $90, and if it can break out, the stock may rise further to $123.
As the vaccine news comes out very often lately, US stock market have rallied to new all time highs. With the backdrop of weakening dollar and soaring precious metals prices, Brazil will benefit since it has huge dollar denominated debt.
EWZ has corrected 9 months. On 12/1/2020, price broke out of pivot $33.4. The space up to $43.3 have very little trading...
After MRNA , PFE , AZE's great vaccine trial result, the group has gained momentum today. The market is optimistic about NVAX's coming result and pushed price above pivot $113. The 4 month correction of 59% is finished and there is a chance for NVAX to challenge previous high at $188 if the vaccine result is good. However, it is a risky bet since the vaccine trial...
ZI is a SaaS with 50+% revenue growth. However the price wasn't enjoy much of the tech hype and formed a 5 month base. The lockup period will expire next week (12/1). Look for a final pull back at near 20wma and then buy at breakout of pivot $46.5 .
Today with manufacturing PMI at 55.3, better than concensus, ended the uptrend since March 7, 2019. The sharp pull back is now oversold in RSI and KD. Further selling is not recommended. Since recent uptrend was strong, this pull back is more likely to form a sideway range 148~150'20. But a weak rebound might suggest a ABC correction further below today's low 148.